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Introduction
Peripheral artery disease (PAD) is a significant medical 
concern because it is a highly prevalent,1–3 costly,4–7 and 
deadly condition.8,9 The global prevalence of PAD increased 
by 23.5% from 2000 to 2010,1 resulting in a prevalence of 
202 million people worldwide, affecting 15–20% of indi-
viduals over 70 years of age.1 PAD is associated with ele-
vated cardiovascular risk, as the combined event rate of 
myocardial infarction, stroke, revascularization, and vascu-
lar death is 6% per year.2 Furthermore, the annual cost paid 
by Medicare related to PAD is $3.9 billion in the United 
States alone,4 and this cost is expected to increase dramati-
cally in the future. Development of leg symptoms further 
complicates the clinical course of PAD, resulting in ambu-
latory dysfunction.10–12
Supervised exercise therapy is highly efficacious in treat-
ing symptomatic PAD.13 Recently, we adopted a new model 
of exercise therapy for patients with PAD by exporting the 
exercise program to the home and community environment, 
while rigorously quantifying the amount of ambulation 
achieved during the training sessions.14 Our step-monitored 
home-based exercise program has low attrition, high adher-
ence, and is efficacious for improving exercise and vascular 
outcome measures,14 such as claudication onset time (COT), 
peak walking time (PWT), 6-minute walk distance (6MWD), 
a community-based daily ambulatory activity, vascular 
function, inflammation, and calf muscle hemoglobin oxy-
gen saturation.14,15
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Because a home exercise program is less standardized 
than a center-based, supervised exercise program, it is impor-
tant to determine whether more responsive patients can be 
identified at baseline prior to enrollment, and whether the 
amount of exercise completed is associated with efficacy. 
These issues are likely to be sex-specific, given our previous 
findings that women have greater impairment in baseline 
ambulation16,17 vascular function,18,19 and inflammation,20 
and that women, particularly those with diabetes, have less 
increase in COT and PWT following exercise training.21
To address these issues, we performed a follow-up anal-
ysis to our recent prospective, randomized controlled exer-
cise trial in symptomatic patients with PAD.15 Our specific 
aim was to determine whether baseline clinical characteris-
tics and the duration and intensity of ambulation during our 
step-monitored home-based exercise program were predic-
tive of the changes in ambulatory outcome measures of 
COT, PWT, and 6MWD at completion of the program in 
symptomatic patients with PAD.
Methods
Patients
Approval and informed consent. The institutional review board 
at the University of Oklahoma Health Sciences Center 
(HSC), and the Research and Development committee at 
the Oklahoma City VA Medical Center approved the proce-
dures of this study. Written informed consent was obtained 
from each patient at the beginning of investigation.
Recruitment. Patients were recruited from vascular labs and 
vascular clinics from the University of Oklahoma HSC and 
the Oklahoma City VA Medical Center.
Baseline clinical characteristics obtained 
from a medical history and physical 
examination
Patients were evaluated in the morning at the Clinical 
Research Center at the University of Oklahoma HSC. 
Patients arrived fasted, but were permitted to take their usual 
medications. To begin the study visit, patients were evalu-
ated with a medical history and physical examination in 
which demographic information, height, mass, waist circum-
ference, cardiovascular risk factors, comorbid conditions, 
claudication history, ankle-brachial index (ABI), blood sam-
ples, and a list of current medications were obtained.
Inclusion and exclusion criteria. Patients with symptomatic PAD 
were included in this study if they met the following criteria: 
(a) a history of ambulatory leg pain, (b) ambulatory leg pain 
confirmed by treadmill exercise,10 and (c) an ABI ⩽ 0.903 at 
rest or ⩽ 0.73 after exercise.22 Patients were excluded for the 
following conditions: (a) absence of PAD (ABI > 0.90 at rest 
and ABI > 0.73 after exercise), (b) non-compressible vessels 
(ABI ⩾ 1.40), (c) asymptomatic PAD, (d) use of medications 
indicated for the treatment of claudication (cilostazol or pent-
oxifylline) initiated within 3 months prior to investigation, (e) 
exercise limited by other diseases or conditions, (f) active 
cancer, (g) end-stage renal disease defined as stage 5 chronic 
kidney disease, (h) abnormal liver function, (i) failure to com-
plete all of the baseline tests in a 3-week baseline run-in 
phase, and (j) failure to complete more than one-third (>12) 
of the exercise intervention sessions. A total of 60 patients 
were enrolled in the home exercise program, of which seven 
patients did not complete the study and seven others com-
pleted only 12 or fewer of the prescribed 36 exercise sessions. 
Thus, 46 patients who successfully completed the study were 
included in the analyses.
Step-monitored home-based exercise 
rehabilitation program
We used a small (75 × 50 × 20 mm), lightweight (38 g) step 
activity monitor (StepWatch3TM; Orthoinnovations, Inc., 
Oklahoma City, OK, USA) to accurately record the dura-
tion and cadence of ambulation during each exercise ses-
sion.14,15 The step activity monitor is programmed by 
placing the unit on a USB docking station connected to a 
computer with StepWatch3TM Analysis Software. Once 
programmed, the monitor records the number of steps taken 
on a minute-to-minute basis for up to 2 months. Data are 
downloaded by placing the monitor on the USB docking 
station, and saving the patient file containing the number of 
minutes spent walking and the number of steps taken dur-
ing each minute of walking. Once data are saved as a patient 
file, the step activity monitor is re-programmed while on 
the docking station to begin a new recording cycle.
This home-based exercise program consisted of 3 months 
of intermittent walking. Patients were instructed to walk to 
mild-to-moderate claudication pain at least 3 days per week 
at a self-selected pace, in which exercise duration was pro-
gressively increased from 20 to 45 minutes per session. 
Patients were given a step activity monitor with an attached 
elastic Velcro fastener strap, and were instructed to wear the 
monitor around their right ankle above the lateral malleolus 
during each exercise session, and then remove the monitor 
at the completion of each session. Additionally, they 
received an exercise logbook to record their walking ses-
sions. Patients returned their monitors and logbooks to the 
research staff at the end of weeks 1, 4, 8, and 12. During 
these brief 15-minute meetings, monitor data were down-
loaded, results were reviewed, and feedback was provided 
for the upcoming month of training. The total contact time 
that staff spent with each patient during the four study visits 
in the home exercise program was approximately 1 hour, 
with only several additional minutes being required at the 
end of the final baseline test visit prior to beginning the pro-
gram to instruct patients how to properly use and wear the 
step activity monitor. The accuracy of the step activity mon-
itor exceeds 99% ± 1% compared to hand-tallied step counts 
in patients with claudication, and the test–retest intraclass 
reliability coefficient for the daily ambulatory activity meas-
ures range from R=0.83 to R=0.94.23
Primary outcome measures
COT and PWT obtained from a graded maximal treadmill 
test. Patients performed a graded treadmill test to deter-
mine study eligibility, and then repeated the test on a fol-
lowing visit within 1 week to obtain the primary outcome 
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measures of COT and PWT as previously described.10,14 
Using our procedures, the test–retest intraclass reliability 
coefficient is R=0.89 for COT10 and R=0.93 for PWT.10
Total walk distance obtained from a 6-minute walk test. On a 
separate day, typically within 1 week from the final tread-
mill test, patients performed an over-ground, 6-minute 
walk test supervised by trained exercise technicians, as pre-
viously described from our laboratory.24 The total distance 
walked during the test was recorded. The test–retest intra-
class reliability coefficient is R=0.94 for the total 6-minute 
walking distance.24
Statistical analyses
In an initial analysis, large differences between men and 
women were observed in the linear associations among 
the baseline variables and change scores (Figure 1). Hence, 
each sex was examined separately. While estimates obtained 
in within-sex analyses are valid irrespective of any interac-
tions with sex, it was of interest to examine the interaction 
of sex and all predictor variables in multivariate models. 
Multiple regression models with interaction terms of sex 
and predictor variables for both sexes were used to detect 
significant interactions between sexes. The presence of 
interactions indicated the inappropriateness of combining 
data from both sexes.
The baseline treadmill variables exhibited significant 
skewing and were summarized as medians and interquartile 
ranges. Wilcoxon tests were used for testing these varia-
bles. Other measurement variables at baseline were sum-
marized within each sex as means and standard deviations, 
and independent t-tests were used for testing among pairs 
of means. Dichotomous variables were summarized as per-
cent with attribute present and were compared between 
sexes using a single degree of freedom chi-squared test. 
A similar test of baseline variables between evaluable 
subjects and others revealed no significant differences. 
Effects of exercise intervention measures were compared 
for both men and women within each sex as the time sim-
ple effects of a two time by two group ANOVA with 
repeated measures on time. The interaction term was used 
to compare differences in simple effects across groups. 
Note that these tests assume normality only for the change 
scores and not for the baseline and post-test measures.
Multivariate regression predictor models for values of 
outcome variables after completion of the home exercise 
program were obtained using an iterative least square pro-
cedure with baseline variables and exercise training varia-
bles as possible predictors. The variable producing the 
largest R2 value was entered first and the variable produc-
ing the largest change in R2 was entered in each subsequent 
step. To avoid over parameterization, additional variables 
were restricted to only those with a p-value <0.10. 
Associations among pairs of variables were measured using 
correlations. Correlations (unlike test of means, which are 
very robust relative to normal distribution assumptions) are 
often sensitive to departure from normal. The distributions 
of treadmill variables for females exhibited some depar-
tures from normal; therefore, Spearman correlations were 
reported for these variables, and are presented in italics 
in tables. Pearson correlations were used for all other varia-
bles. All computations were made with the NCSS computer 
package (Kaysville, UT, USA).
Results
Baseline clinical characteristics
The clinical characteristics of the men and women in this 
study are shown in Table 1. The groups had mean ABI, COT, 
and PWT values typical for symptomatic PAD, and consisted 
of a mix of older, overweight Caucasians and African 
Americans with a high prevalence of cardiovascular risk fac-
tors. The women had significantly lower 6MWD (p < 0.01) 
and lower body mass (p < 0.01) values than the men.
Exercise intervention and changes in 
ambulatory outcome measures
Exercise training measures and ambulatory outcome 
change scores are shown in Table 2. The total number of 
exercise sessions completed, the average exercise time per 
session, and the average strides taken per session were not 
significantly different between the men and women, but the 
women performed their exercise sessions at a slower ambu-
latory cadence than the men (p < 0.01). Men experienced 
significant increases (p < 0.01) in COT, PWT, and 6MWD 
following the home exercise program. Women had signifi-
cant increases in 6MWD (p < 0.01) and PWT (p < 0.05), 
but not for the change in COT (p > 0.05). The change scores 
for COT, PWT, and 6MWD were not significantly different 
between men and women.
Correlates of the changes in ambulatory 
outcome measures
The strongest univariate correlates of the change in ambu-
latory outcomes are displayed in Table 3. In women, the 
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Figure 1. Scatterplot of change in peak walking time (PWT) 
and average cadence during exercise training sessions with 
corresponding regression lines in men (slope = 3.4326 seconds/
stride, p = 0.4993) and in women (slope = 12.6274 seconds/
stride, p = 0.0192) with symptomatic peripheral artery disease.
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average exercise cadence during the home exercise training 
sessions was the highest univariate correlate (positive) with 
the change in 6MWD (p < 0.05) and in COT, whereas race 
was the highest correlate with the change in PWT (p < 0.05), 
with caucasian women having more favorable improvements. 
In men, the ABI was the highest univariate correlate (posi-
tive) with the change in 6MWD (p < 0.01), whereas meta-
bolic syndrome and age were the highest correlates (negative) 
with changes in COT (p < 0.05) and PWT, respectively.
Multivariate regression predictors of 
changes in ambulatory outcome measures
In the entire sample of patients, two significant interactions 
were detected for the change in COT predictors and sex, 
consisting of sex by average exercise cadence (p = 0.024) and 
sex by metabolic syndrome (p = 0.007). For the change in 
PWT, sex by average exercise cadence approached signifi-
cance (p = 0.075). For the change in 6MWD, both sex by ABI 
(p = 0.001) and sex by average exercise cadence (p = 0.001) 
interactions were significant.
In women, the multivariate regression models identify-
ing predictors of the changes in ambulatory outcomes are 
presented in Table 4. The average exercise cadence during 
the home exercise training sessions was the only predictor 
that entered the model for the change in COT (p = 0.082), 
and was the first predictor in the model for the change in 
PWT (p = 0.029) and in 6MWD (p = 0.006). In contrast to 
these results in women, for men the average exercise 
cadence during the home exercise sessions was not a 
Table 1. Baseline clinical characteristics of men and women with symptomatic peripheral artery disease who completed the step-
monitored home exercise program.
Variables Men (n = 22) Women (n = 24)
Age, years 66 (11) 68 (11)
Ankle–brachial index 0.71 (0.19) 0.66 (0.23)
Mass, kg 93.2 (14.4) 73.2 (14.3)a
Height, cm 178.0 (4.8) 160.9 (5.6)b
Body mass index, kg/m2 29.4 (4.3) 28.3 (5.6)
Characteristics present, %  
Caucasian 59 63
Current smoking 23 42
Hypertension 86 92
Dyslipidemia 82 88
Diabetes 36 46
Obesity 41 42
Abdominal obesity 55 58
Metabolic syndrome 82 92
Lower extremity revascularization 27 50
Angina 27 21
Cerebral vascular accident 18 33
Chronic obstructive pulmonary disease 14 33
Data presented as mean (SD) and percent.
Different than men: ap < 0.01, bp < 0.001.
Table 2. Exercise measures and ambulatory outcome change scores.
Variables Men (n = 22) Women (n = 24)
Exercise training measures: mean (SD)  
Exercise sessions completed, n 35 (10) 29 (9)
Average exercise time, minutes/exercise session 41.0 (19.9) 40.2 (19.1)
Average exercise strides, strides/exercise session 1660 (641) 1411 (656)
Average exercise cadence, strides/minute 41.2 (8.5) 35.4 (8.4)a
Baseline ambulatory measures: median (IQR)  
Claudication onset time, seconds 158 (172) 136 (199)
Peak walking time, seconds 392 (406) 255 (342)
6-minute walk distance, meters 416 (125) 267 (141)a
Change scores of ambulatory outcome measures: mean (SD)  
Change in claudication onset time, seconds 142 (162)b 80 (196)
Change in peak walking time, seconds 136 (192)b 99 (225)c
Change in 6-minute walk distance, meters 42 (64)b 56 (47)b
IQR, interquartile range.
Different than men: ap < 0.01.
Change different from zero: bp < 0.01, cp< 0.05.
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significant predictor of change in PWT (Figure 1), COT, or 
6MWD. In men (Table 5), ABI was the only predictor that 
entered the model for change in 6MWD (p = 0.002), 
and was a predictor along with metabolic syndrome and 
body mass in the model for change in COT (p = 0.003). No 
variables entered the model for change in PWT.
Discussion
A primary novel finding was that for women with sympto-
matic PAD, performing the step-monitored home-based 
exercise training sessions at faster ambulatory cadence was 
predictive of greater increases in COT, PWT, and 6MWD at 
completion of the program. In men, a higher baseline ABI 
was predictive of greater increases in COT and 6MWD, 
whereas having metabolic syndrome at baseline was pre-
dictive of less improvement in COT.
Exercise adherence and efficacy
Adherence to the step-monitored home-based exercise pro-
gram was high in the patients, as more than 86% of the men 
and 79% of the women completed at least two-thirds of the 
prescribed total of 36 exercise sessions in the program (three 
sessions per week for 12 weeks). One particular advantage of 
the home exercise program, compared to the traditional 
approach using an on-site supervised exercise program, is 
that patients have the freedom to over-achieve by completing 
more than the 36 prescribed sessions. In fact, 36% of the men 
and 29% of the women completed more than 36 sessions, 
with the maximum number of completed exercise sessions 
being 57 for men and 49 for women. Another way for patients 
to over-achieve in the home exercise program is to walk for 
longer than the prescribed amount of time during each train-
ing session. The prescribed walking duration progressively 
increased from 20 minutes in the first week to 45 minutes by 
the end, with an average of 40 minutes. Both the men and 
women walked for an average of 8 additional minutes per 
session beyond the prescribed duration. The primary differ-
ence between men and women in performing their home 
exercise sessions was that the women walked at a cadence 
that was 5.8 strides/min (10.6 steps/min) slower than men. 
Collectively, these results indicate that individualized 
monthly feedback is adequate for the majority of patients to 
adhere to the home exercise program. The high adherence 
rate agrees with previous randomized controlled trials using 
a step activity monitor,14,15,25 and a group-mediated cognitive 
behavioral intervention.26,27
Table 3. Four strongest univariate correlates of the change in ambulatory outcomes with baseline characteristics and exercise 
training measures in symptomatic patients with peripheral artery disease.
Group ∆ COT ∆ PWT ∆ 6-MWD
Women
 
 
 
 
 
Average exercise cadence (r = 0.36) Race (r = 0.43)a Average exercise cadence (r = 0.48)a
Age (r = 0.35) Age (r = 0.39) Lower extremity revascularization  
(r = 0.39)
Current smoking (r = −0.26) Current smoking (r = −0.32) Chronic obstructive pulmonary 
disease (r = −0.39)
Ankle–brachial index (r = 0.20) Average exercise cadence (r = 0.27) Total exercise time (r = 0.33)
Men  
 Metabolic syndrome (r = −0.48)a Age (r = −0.24) Ankle–brachial index (r = 0.63)b
 Total exercise time (r = 0.41)a Current smoking (r = 0.23) Metabolic syndrome (r = 0.37)
 Ankle–brachial index (r = 0.36) Average exercise cadence (r = 0.15) Average exercise cadence (r = 0.27)
 Current smoking (r = 0.25) Ankle–brachial index (r = 0.12) Lower extremity revascularization  
(r = −0.23)
COT, claudication onset time; PWT, peak walking time; 6-MWD, 6-minute walk distance.
Values are Pearson partial correlation coefficients or Spearman partial correlation coefficients (indicated in italicized print).
Race was coded as 0 = African American and 1 = Caucasian.
ap < 0.05, bp < 0.01.
Table 4. Multivariate regression models identifying predictors of the changes in ambulatory outcomes in women with symptomatic 
peripheral artery disease.
Dependent variables Predictors Regression coefficient Partial correlations p-values
∆ COT (s) Average exercise cadence 10.73 0.36 0.082
 Intercept −299.16  
∆ PWT (s) Average exercise cadence 16.78 0.46 0.029
 Lower extremity revascularization −176.12 −0.45 0.032
 Intercept −406.48  
∆ 6-MWD (m) Average exercise cadence 3.25 0.59 0.006
 Ankle–brachial index −82.90 −0.44 0.055
 Intercept −2.87  
COT, claudication onset time; PWT, peak walking time; 6-MWD, 6-minute walk distance.
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The step-monitored home-based exercise program 
resulted in significant improvements in COT, PWT, and 
6MWD in men, and in PWT and 6MWD in women. There 
was a non-significant trend for the COT change score to 
also increase in women. These findings support previous 
work reporting improvements in COT, PWT, and 6MWD 
following home-based exercise.14,15,25,26 Interestingly, we 
recently found that there is a specificity to training such that 
supervised treadmill training elicits greater improvements 
in treadmill outcomes (COT and PWT) than over-ground 
home exercise training, whereas the home exercise pro-
gram elicits greater improvements in 6MWD.15 However, it 
is important to note that there are considerable cross-over 
effects, as both programs resulted in improvements in COT, 
PWT, and 6MWD. The current study highlights this cross-
over effect by demonstrating that over-ground walking per-
formed in the step-monitored home-based exercise program 
results in significant increases in PWT during treadmill 
tests in men and women with PAD.
Predictors of changes in ambulatory 
outcomes
This is the first study to report the association between the 
ambulatory cadences performed during exercise sessions in 
a home exercise program with the change scores in ambula-
tory outcome measures. Ambulatory cadence is important 
because it represents the intensity, or pace, at which the 
exercise was accomplished during the home exercise pro-
gram. The primary finding was that ambulatory cadence 
was a predictor of the changes in COT, PWT, and 6MWD 
in women with symptomatic PAD. This finding indicates 
that women who walked at a relatively fast cadence experi-
enced the greatest improvements in function, and women 
who walked slower experienced less improvement, perhaps 
because they were not training at sufficient intensity. It is 
therefore possible that the instructions given to women par-
ticipating in a home exercise program should be modified 
by having them perform their exercise sessions at a pace 
that is equal to or faster than their self-selected pace.
Men experienced improvements in all three ambula-
tory outcomes (COT, PWT, and 6MWD) following the 
home exercise program. In contrast to women, baseline 
characteristics such as ABI, metabolic syndrome, and 
body mass were more predictive of the improvements 
in the outcome measures than the ambulatory cadence 
during exercise training sessions. For example, men who 
had a relatively low ABI and metabolic syndrome at base-
line were less responsive to the home exercise program. 
This finding suggests that men who have more severe 
PAD and comorbid burden at baseline may either need 
a greater dose of exercise in the home exercise program, 
or additional medical intervention to supplement with 
exercise, or both, to elicit more optimal improvements in 
ambulatory outcomes.
Limitations
Although this trial supports the efficacy of the step-moni-
tored home-based exercise program for men and women 
with PAD, several limitations exist. One limitation is that 
patients volunteered to participate in this study. Thus, a 
self-selection bias may exist because they may represent 
those who had greater interest in participating, better access 
to transportation to the research center, and better health 
than PAD patients who did not volunteer. A second limita-
tion is that the results of this study are only generalizable to 
patients with symptomatic PAD, and may not be applicable 
to patients with less severe or more severe PAD. Another 
limitation is that, by definition, we chose to study only 
those who successfully adhered to and completed the exer-
cise program (46 out of 60) because we were interested in 
describing the true potential of the home exercise program 
to change ambulatory outcome measures if successfully 
performed. We have already reported the efficacy of this 
exercise program using several methods to rigorously 
account for bias due to dropping out of the study or poorly 
attending the program.14,15 These methods included using 
an intent-to-treat analytic strategy, including into the analy-
ses those patients who completed the study but who had 
low adherence rates to the intervention, and comparing the 
baseline characteristics of patients who completed with 
those who did not complete. We believe there is minimal 
bias associated with failing to complete or poorly attending 
the program because similar results were obtained using 
intent-to-treat versus completer analyses, and because the 
baseline characteristics of drop outs were not different than 
those who completed the study.14,15 Another potential study 
limitation is that although the comorbid conditions were 
not statistically different between men and women, the 
women tended to have more clustering of comorbid condi-
tions, which in aggregate could have contributed to their 
Table 5. Multivariate regression models identifying predictors of the changes in ambulatory outcomes in men with symptomatic 
peripheral artery disease.
Dependent variables Predictors Regression coefficient Partial correlations p-values
∆ COT (s) Metabolic syndrome −293.12 −0.70 0.001
 Ankle–brachial index 503.98 0.63 0.003
 Mass 3.78 0.42 0.067
 Intercept −330.51  
∆ PWT (s) None  
∆ 6-MWD (m) Ankle–brachial index 215.66 0.63 0.002
 Intercept −111.93  
COT, claudication onset time; PWT, peak walking time; 6-MWD, 6-minute walk distance.
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slower cadence during training sessions and relatively 
smaller improvement. One approach may have been to 
adjust for baseline covariates in an ANCOVA model, but 
this could not be done because the assumptions of ANCOVA 
were not met. A final limitation is that the sample size was 
small, which limits the ability to identify significant corre-
lates of the exercise change scores, and it provides less pre-
cise estimates of change scores than if a larger sample were 
available. However, it should be noted that even with a 
small sample size, all of the ambulatory change scores in 
men and women, except for COT in women, were signifi-
cant due to the large effect sizes associated with the home 
exercise program, and that predictors of the change scores 
were identified in multivariate models.
Conclusions and clinical significance
We conclude that faster ambulatory cadence during the 
step-monitored home-based exercise program may predict 
greater improvements in ambulatory function in women, 
whereas having less severe PAD and comorbid burden at 
baseline may predict greater improvements in ambulatory 
function in men. However, since this study was a follow-up 
analysis on a subset of patients from our recent prospective, 
randomized controlled exercise trial on a larger number of 
symptomatic patients with PAD,15 the current findings are 
preliminary and require confirmation in future investiga-
tions. The clinical significance may be that the pace of 
ambulating during the exercise sessions of the home exer-
cise program should be carefully monitored at regular inter-
vals to ensure that the exercise is performed at sufficient 
intensity to elicit more optimal ambulatory improvements 
in symptomatic patients with PAD.
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